0001127602-19-010841.txt : 20190311 0001127602-19-010841.hdr.sgml : 20190311 20190311171622 ACCESSION NUMBER: 0001127602-19-010841 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190308 FILED AS OF DATE: 20190311 DATE AS OF CHANGE: 20190311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE JENNIFER LING CENTRAL INDEX KEY: 0001675118 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 19673109 MAIL ADDRESS: STREET 1: C/O FLUIDIGM CORPORATION STREET 2: 7000 SHORELINE COURT SUITE 100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-03-08 0001682852 Moderna, Inc. MRNA 0001675118 LEE JENNIFER LING C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Accounting Officer Common Stock 2019-03-08 4 A 0 4780 0 A 4780 D Stock Option (Right to Buy) 20.93 2019-03-08 4 A 0 25097 0 A 2020-03-08 2029-03-08 Common Stock 25097 25097 D 25% of the shares subject to this restricted stock unit award will vest on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of this option will vest and become exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. /s/ Jeffrey Cerio, as Attorney-in-Fact 2019-03-11